AAAAAA

   
Results: 1-6 |
Results: 6
Role of the 4G/5G polymorphism of PAI-1 gene promoter on PAI-1 levels in obese patients - Influence of fat distribution and insulin-resistance
Authors: Sartori, MT Vettor, R De Pergola, G De Mitrio, V Saggiorato, G Della Mea, P Patrassi, GM Lombardi, AM Fabris, R Girolami, A
Citation: Mt. Sartori et al., Role of the 4G/5G polymorphism of PAI-1 gene promoter on PAI-1 levels in obese patients - Influence of fat distribution and insulin-resistance, THROMB HAEM, 86(5), 2001, pp. 1161-1169
Beneficial effects of postmenopausal hormone replacement therapy with transdermal estradiol on sensitivity to activated protein C
Authors: De Mitrio, V Marino, R Cicinelli, E Galantino, P Di Bari, L Giannoccaro, F De Pergola, G Lapecorella, M Schonauer, S Schiraldi, O
Citation: V. De Mitrio et al., Beneficial effects of postmenopausal hormone replacement therapy with transdermal estradiol on sensitivity to activated protein C, BL COAG FIB, 11(2), 2000, pp. 175-182
Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation
Authors: De Mitrio, V Marino, R Scaraggi, FA Di Bari, L Giannoccaro, F Petronelli, M Ranieri, P Tannoia, N Schiraldi, O
Citation: V. De Mitrio et al., Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation, BL COAG FIB, 10(7), 1999, pp. 409-416
Is activated protein C resistance following orthotopic liver transplantation a risk factor for venous thrombosis?
Authors: De Mitrio, V Marino, R Rendina, M Di Bari, L Francavilla, A Schiraldi, O
Citation: V. De Mitrio et al., Is activated protein C resistance following orthotopic liver transplantation a risk factor for venous thrombosis?, BL COAG FIB, 10(4), 1999, pp. 211-212
Treatment with recombinant activated factor VII in a patient with hemophilia A and an inhibitor: advantages of administration by continuous infusion over bolus intermittent injections
Authors: Scaraggi, FA De Mitrio, V Marino, R Speciale, V Di Bari, L Petronelli, M Schiraldi, O
Citation: Fa. Scaraggi et al., Treatment with recombinant activated factor VII in a patient with hemophilia A and an inhibitor: advantages of administration by continuous infusion over bolus intermittent injections, BL COAG FIB, 10(1), 1999, pp. 33-38
Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women
Authors: De Mitrio, V De Pergola, G Vettor, R Marino, R Sciaraffia, M Pagano, C Scaraggi, FA Di Lorenzo, L Giorgino, R
Citation: V. De Mitrio et al., Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women, METABOLISM, 48(8), 1999, pp. 960-964
Risultati: 1-6 |